| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.02 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |